Simulations Plus (NASDAQ:SLP) Sets New 12-Month Low on Analyst Downgrade

Simulations Plus, Inc. (NASDAQ:SLP)’s share price hit a new 52-week low on Wednesday after KeyCorp lowered their price target on the stock from $40.00 to $35.00. KeyCorp currently has an overweight rating on the stock. Simulations Plus traded as low as $26.51 and last traded at $26.51, with a volume of 24606 shares changing hands. The stock had previously closed at $30.39.

A number of other research firms also recently weighed in on SLP. StockNews.com downgraded Simulations Plus from a “hold” rating to a “sell” rating in a research report on Monday, November 4th. William Blair restated an “outperform” rating on shares of Simulations Plus in a research report on Wednesday. BTIG Research cut their target price on Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research note on Thursday, October 24th. Finally, Stephens started coverage on shares of Simulations Plus in a research note on Friday, November 15th. They set an “overweight” rating and a $39.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $49.00.

Insider Buying and Selling at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $31.76, for a total value of $635,200.00. Following the transaction, the director now directly owns 3,442,584 shares in the company, valued at $109,336,467.84. The trade was a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 19.40% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of SLP. State Street Corp increased its holdings in Simulations Plus by 4.7% during the 3rd quarter. State Street Corp now owns 640,303 shares of the technology company’s stock valued at $20,503,000 after purchasing an additional 28,953 shares in the last quarter. Geode Capital Management LLC lifted its position in Simulations Plus by 4.4% during the 3rd quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company’s stock worth $14,367,000 after buying an additional 18,924 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in Simulations Plus by 10.1% during the 2nd quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock worth $20,128,000 after buying an additional 37,992 shares in the last quarter. Tributary Capital Management LLC increased its position in Simulations Plus by 54.7% in the 3rd quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company’s stock valued at $10,425,000 after acquiring an additional 115,122 shares in the last quarter. Finally, Royce & Associates LP raised its stake in shares of Simulations Plus by 28.8% in the third quarter. Royce & Associates LP now owns 237,416 shares of the technology company’s stock worth $7,602,000 after acquiring an additional 53,092 shares during the last quarter. Institutional investors own 78.08% of the company’s stock.

Simulations Plus Stock Down 1.5 %

The stock’s 50-day moving average price is $29.81 and its 200-day moving average price is $33.96. The company has a market capitalization of $558.36 million, a price-to-earnings ratio of 56.74 and a beta of 0.80.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 EPS for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. The firm had revenue of $18.70 million for the quarter, compared to analyst estimates of $19.73 million. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The business’s quarterly revenue was up 19.9% compared to the same quarter last year. During the same period last year, the company earned $0.18 EPS. On average, equities research analysts anticipate that Simulations Plus, Inc. will post 1.1 EPS for the current year.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.